Abstract
In this issue of Blood, McKerrell et al describe a novel next-generation sequencing (NGS)-based platform for the identification of point mutations, common fusion genes, and copy-number alterations in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) from a single genomic DNA sample.
Cite
CITATION STYLE
APA
Dillon, R., & Grimwade, D. (2016). Just 1 test to diagnose AML?!! Blood, 128(1), 7–8. https://doi.org/10.1182/blood-2016-05-715060
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free